secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2022-07-25T23:59:59+00:00
Accession:  0000950170-22-012986
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace reports Q2 2022 revenue $351.2M (+26.2% YoY), diluted EPS $1.46 vs $1.06
--------------------------------------------------------------------------------

- Revenue $351.2M, up 26.2% YoY; constant currency organic growth 27.7%.
- GAAP net income $49.4M ($1.46 diluted EPS) vs $39.9M ($1.06) YoY.
- Net new business awards $450.6M (book-to-bill 1.28x), up 16.3% YoY.
- Backlog $2.2B, up 24.4% from $1.7B YoY.
- EBITDA $68.1M (19.4% margin), up 42% YoY from $47.9M (17.2%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022012986/0000950170-22-012986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000095017022012986/medp-20220725.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-012986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer